Cuproptosis in ccRCC: key player in therapeutic and prognostic targets

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets

BackgroundClassical biomarkers have been used to classify clear cell renal cell carcinoma (ccRCC) patients in a variety of ways, and emerging evidences have indicated that cuproptosis is closely related to mitochondrial metabolism, thereby accelerating the development and progression of ccRCC. Never...

Full description

Bibliographic Details
Main Authors:	Yang Lv, Qiang Li, Lu Yin, Shaohua He, Chao Qin, Zhongwen Lu, Hongqi Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Oncology
Subjects:	clear cell renal cell carcinoma cuproptosis tumor immune microenvironment immunotherapy prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1271864/full

Similar Items

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
by: Binxiang Chu, et al.
Published: (2022-09-01)

Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
by: Zhulin Wu, et al.
Published: (2020-11-01)

Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
by: Qiu Zhengqi, et al.
Published: (2021-01-01)

Does the Urinary Proteome Reflect ccRCC Stage and Grade Progression?
by: Lucia Santorelli, et al.
Published: (2021-12-01)

Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
by: Lingqin Li, et al.
Published: (2023-08-01)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
by: Siming Chen, et al.
Published: (2021-02-01)

Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
by: Rita de Cássia Oliveira, et al.
Published: (2017-12-01)

Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
by: Dian Xia, et al.
Published: (2023-03-01)

Identification of AKI signatures and classification patterns in ccRCC based on machine learning
by: Li Wang, et al.
Published: (2023-05-01)

Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma
by: Hu Wang, et al.
Published: (2023-08-01)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
by: Mingzhe Li, et al.
Published: (2022-10-01)

Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study
by: Aimin Jiang, et al.
Published: (2022-08-01)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
by: Binfeng Liu, et al.
Published: (2022-10-01)

Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database
by: Bangbei Wan, et al.
Published: (2020-04-01)

Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma
by: Jiajin Wu, et al.
Published: (2023-06-01)

Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma
by: Maoshu Zhu, et al.
Published: (2023-07-01)

Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma
by: Tuanjie Guo, et al.
Published: (2022-12-01)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
by: Hao Dong, et al.
Published: (2023-01-01)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
by: Lei Ding, et al.
Published: (2022-09-01)

Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma
by: Yi-Pan Zhu, et al.
Published: (2023-04-01)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
by: Xu Wang, et al.
Published: (2023-03-01)

Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator <i>FDX1</i> in Clear Cell Renal Cell Carcinoma
by: Song Zeng, et al.
Published: (2022-09-01)

CD146 as a Prognostic-Related Biomarker in ccRCC Correlating With Immune Infiltrates
by: Zheng Lv, et al.
Published: (2021-12-01)

Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
by: Gang Luo, et al.
Published: (2023-05-01)

Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
by: Qiang Song, et al.
Published: (2022-08-01)

Comprehensive analysis of cuproptosis‐related gene expression and positive correlations with CD4+ T cell infiltration in head and neck squamous cell carcinoma
by: Zhangwei Hu, et al.
Published: (2023-09-01)

In-Depth Mapping of the Urinary <i>N</i>-Glycoproteome: Distinct Signatures of ccRCC-related Progression
by: Lucia Santorelli, et al.
Published: (2020-01-01)

A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC
by: Yanmei Wang, et al.
Published: (2023-05-01)

Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC)
by: Bai X, et al.
Published: (2021-12-01)

Unveiling the hidden AP-1: revealing the crucial role of AP-1 in ccRCC at single-cell resolution
by: Jie Zheng, et al.
Published: (2023-12-01)

TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression
by: Lingling Xie, et al.
Published: (2023-10-01)

GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)
by: Hua-Hui Wu, et al.
Published: (2021-07-01)

Aging-based molecular classification and score system in ccRCC uncovers distinct prognosis, tumor immunogenicity, and treatment sensitivity
by: Maoshu Zhu, et al.
Published: (2022-08-01)

High Immunoexpression of COX-2 as a Metastatic Risk Factor in ccRCC without PD-L1 Involvement
by: Suryanti S, et al.
Published: (2021-08-01)

Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data
by: Jiang-hui Zeng, et al.
Published: (2019-08-01)

Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer
by: Yatao Wang, et al.
Published: (2024-01-01)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
by: Lishuo Zhang, et al.
Published: (2023-01-01)

Clear-cell renal cell carcinoma(ccRCC) with hemangioblastoma(HB)-like features: A rare case report and literature review
by: Zhen Li, et al.
Published: (2024-04-01)

Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype
by: Mark Farha, et al.
Published: (2023-11-01)

KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction]
by: Yang GH, et al.
Published: (2023-05-01)